SEC Form 4 · accession 0001209191-16-146247
ARROWHEAD PHARMACEUTICALS, INC. · ARWR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Douglas B Given
Director
Period of report
Jan 12, 2016
Accepted (ET)
Oct 18, 2016 · 7:53 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000879407
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jan 12, 2016 | G | 8,000 | $0.00 | D | 82,000 | D | |
| Common StockF1 | Oct 14, 2016 | S | 12,000 | $6.72 | D | 70,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting person which are subject to certain vesting conditions.